Search: onr:"swepub:oai:gup.ub.gu.se/334312" > Indications and man...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03118naa a2200433 4500 | |
001 | oai:gup.ub.gu.se/334312 | |
003 | SwePub | |
008 | 240528s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3343122 URI |
024 | 7 | a https://doi.org/10.1017/S10479511230008722 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Kaski, Juan Pablo4 aut |
245 | 1 0 | a Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy |
264 | 1 | c 2023 |
520 | a Sudden cardiac death is the most common mode of death during childhood and adolescence in hypertrophic cardiomyopathy, and identifying those individuals at highest risk is a major aspect of clinical care. The mainstay of preventative therapy is the implantable cardioverter-defibrillator, which has been shown to be effective at terminating malignant ventricular arrhythmias in children with hypertrophic cardiomyopathy but can be associated with substantial morbidity. Accurate identification of those children at highest risk who would benefit most from implantable cardioverter-defibrillator implantation while minimising the risk of complications is, therefore, essential. This position statement, on behalf of the Association for European Paediatric and Congenital Cardiology (AEPC), reviews the currently available data on established and proposed risk factors for sudden cardiac death in childhood-onset hypertrophic cardiomyopathy and current approaches for risk stratification in this population. It also provides guidance on identification of individuals at risk of sudden cardiac death and optimal management of implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a child | |
653 | a Hypertrophic cardiomyopathy | |
653 | a implantable defibrillator | |
653 | a risk factor | |
653 | a sudden cardiac death | |
700 | 1 | a Kammeraad, Janneke A.E.4 aut |
700 | 1 | a Blom, Nico A.4 aut |
700 | 1 | a Happonen, Juha Matti4 aut |
700 | 1 | a Janousek, Jan4 aut |
700 | 1 | a Klaassen, Sabine4 aut |
700 | 1 | a Limongelli, Giuseppe4 aut |
700 | 1 | a Östman-Smith, Ingegerd,d 1947u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics4 aut0 (Swepub:gu)xostin |
700 | 1 | a Sarquella Brugada, Georgia4 aut |
700 | 1 | a Ziolkowska, Lidia4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för pediatrik4 org |
773 | 0 | t Cardiology in the youngg 33:5, s. 681-698q 33:5<681-698x 1467-1107 |
856 | 4 8 | u https://gup.ub.gu.se/publication/334312 |
856 | 4 8 | u https://doi.org/10.1017/S1047951123000872 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.